Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

129.19
Delayed Data
As of Sep 27
 +2.47 / +1.95%
Today’s Change
67.81
Today|||52-Week Range
131.11
+43.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line15.0M7.4M113.7M38.1M
 
 
 
 
 
Depreciation2.7M2.5M2.8M3.3M
 
 
 
 
 
Total Other Cash Flow10.7M13.3M18.7M28.7M
 
 
 
 
 
Funds From Operations29.2M24.0M48.0M92.4M
 
 
 
 
 
Funds From/For Other Operating Expenses2.8M530.0K4.7M15.6M
 
 
 
 
 
Net Cash Flow - Operating Activities26.4M23.5M43.3M76.8M
 
 
 
 
 
 
InvestingIncrease In Investments-49.4M-87.8M-100.5M-261.7M
 
 
 
 
 
Decrease In Investments42.0M68.3M71.5M219.6M
 
 
 
 
 
Capital Expenditures-2.8M-2.8M-5.2M-15.6M
 
 
 
 
 
Net Assets From Acquisitions 0.000.00-15.7M0.00
 
 
Net Cash Flow Investing-10.3M-22.3M-49.9M-57.7M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale3.5M10.1M11.7M10.9M
 
 
 
 
 
Common Preferred Redeemed-15.0M0.000.000.00
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.00606.0K3.6M
 
 
 
Other Uses - Financing257.0K425.0K2.8M7.3M
 
 
 
 
 
Net Cash Flow - Financing-11.8M9.6M9.5M7.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-862.0K639.0K-1.5M-415.0K
 
 
 
 
 
 
Net Change In Cash4.3M10.8M3.0M26.2M